SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emami to enter neutraceutical mkt, expand pharmacy chain

04 Jul 2011 Evaluate

Emami is gearing up for a major expansion in the healthcare products category with plans to enter neutraceutical business besides expanding its pharmacy chain in the rest of the country. The Rs 3,500-crore group, which runs around 70 pharmacies under 'Frank Ross' brand in Kolkata, is modelling its expansion similar to UK-based Boots retail chain that sells medicines online and provides services like home delivery and free consultation to patients. The Indian neutraceuticals market is estimated to be valued at around USD one billion in 2010, growing at a rate of 7 per cent per annum.

Emami Share Price

423.50 -0.75 (-0.18%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2127.50
Godrej Consumer Prod 1059.55
Dabur India 424.75
Colgate Palmol. (I) 1915.65
P&G Hygiene 9821.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×